t(5;12)(q33;q24) GIT2/PDGFRB
2009-03-01 Jean-Loup Huret   Affiliation1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Clinics and Pathology
Disease
Chronic myeloproliferative disease with eosinophilia
Epidemiology
Only one case to date, a 67-year-old male patient with a five years history of eosinophilia.
Prognosis
The patient was alive and well after 16 months of therapy with imatinib.
Genes Involved and Proteins
Gene name
PDGFRB (platelet-derived growth factor receptor, beta polypeptide)
Location
5q32
Protein description
Comprises an extracellular part with 5 Ig-like C2 type domains, a transmembrane domain, and an intracellular part with a tyrosine kinase domain (made of two tyrosine kinase subdomains) for transduction of the signal. Receptor tyrosine kinase; receptor for PDGFB and PDGFD (Bergsten et al., 2001); forms homodimers, or heterodimer with PDGFRA; upon dimerization, subsequent activation by autophosphorylation of the tyrosine kinase intracellular domains occurs.
Gene name
GIT2 (GIT ArfGAP 2)
Location
12q24.11
Protein description
Numerous isoforms; the longest is made of 759 amino acids; comprises an Arf-GAP domain (amino acids 1-124), zinc-fingers (11-34), ankyrin repeats (132-161, 166-195, 199-228, according to Swiss-Prot), a Spa2-homology domain, a coiled-coil domain (leucine zipper), and a paxillin-binding site (643-679). GIT1 and GIT2 belong to the family of ADP-ribosylation factor GTPase-activating proteins (ARF-GAP). GIT1 and GIT2 form homodimers and heterodimers which bind in oligomeric complex to the p21-activated kinase-interacting exchange factor proteins ARHGEF6 and ARHGEF7, to regulate the small GTP-binding proteins RAC1 and CDC42. Associates with paxillin, and with phospholipase C (PLCG). GIT1 and GIT2 also participate in receptor internalization by regulating membrane trafficking (Hoefen and Berk, 2006).
Result of the Chromosomal Anomaly
Description
5 GIT2 - 3 PDGFRB. In-frame fusion between exon 12 of GIT2, and exon 11 of PDGFRB.
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 22541084 | 2012 | [Heterogenous abnormality polymorphism of gene PDGFRB in myeloid neoplasms and its clinical characteristics]. | 0 |
| 22169300 | 2011 | [Application of reverse transcription-multiplex nested PCR to detect PDGFRB gene rearrangement in myeloproliferative disorders]. | 0 |
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 11331881 | 2001 | PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. | Bergsten E et al |
| 16598076 | 2006 | The multifunctional GIT family of proteins. | Hoefen RJ et al |
| 17296564 | 2007 | Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene. | Walz C et al |
Summary
Fusion gene
GIT2/PDGFRB GIT2 (12q24.11) PDGFRB (5q32) M t(5;12)(q32;q24)|GIT2/PDGFRB GIT2 (12q24.11) PDGFRB (5q32) TIC
Citation
Jean-Loup Huret
t(5;12)(q33;q24) GIT2/PDGFRB
Atlas Genet Cytogenet Oncol Haematol. 2009-03-01
Online version: http://atlasgeneticsoncology.org/haematological/1544/t(5
